Clinical trial
Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV and Elevated Triglycerides
NCT06058845 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV and Elevated Triglycerides
- Lead sponsor
- KU Leuven
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2023
- Completion date
- January 30, 2024
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiometabolic syndrome, dyslipidemias, hypertension